Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 11 | 2025 | 46 | 5.060 |
Why?
|
| Range of Motion, Articular | 5 | 2020 | 63 | 1.740 |
Why?
|
| Gait Disorders, Neurologic | 4 | 2020 | 9 | 1.440 |
Why?
|
| Postural Balance | 3 | 2024 | 41 | 1.430 |
Why?
|
| Transcranial Direct Current Stimulation | 6 | 2022 | 14 | 1.400 |
Why?
|
| Dancing | 3 | 2024 | 16 | 1.220 |
Why?
|
| Stroke | 6 | 2022 | 249 | 1.200 |
Why?
|
| Dance Therapy | 2 | 2024 | 3 | 1.090 |
Why?
|
| Physical Stimulation | 4 | 2020 | 72 | 1.040 |
Why?
|
| Gait | 4 | 2020 | 61 | 0.900 |
Why?
|
| Walking | 2 | 2020 | 134 | 0.770 |
Why?
|
| Insulin Resistance | 1 | 2023 | 173 | 0.720 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2023 | 123 | 0.720 |
Why?
|
| Carotid Artery Diseases | 1 | 2020 | 37 | 0.680 |
Why?
|
| Secondary Prevention | 1 | 2020 | 46 | 0.680 |
Why?
|
| Ischemic Attack, Transient | 1 | 2020 | 25 | 0.680 |
Why?
|
| Quality of Life | 3 | 2023 | 484 | 0.660 |
Why?
|
| Leg | 1 | 2020 | 134 | 0.660 |
Why?
|
| Aged | 16 | 2025 | 5383 | 0.660 |
Why?
|
| Aspirin | 1 | 2020 | 124 | 0.640 |
Why?
|
| Hydrotherapy | 1 | 2019 | 3 | 0.630 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 329 | 0.620 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2020 | 191 | 0.620 |
Why?
|
| Movement | 1 | 2019 | 97 | 0.610 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 364 | 0.610 |
Why?
|
| Neurological Rehabilitation | 1 | 2018 | 3 | 0.600 |
Why?
|
| Humans | 30 | 2025 | 27968 | 0.580 |
Why?
|
| Pain Management | 1 | 2018 | 57 | 0.580 |
Why?
|
| Chronic Pain | 1 | 2018 | 60 | 0.550 |
Why?
|
| Neuralgia | 3 | 2024 | 18 | 0.540 |
Why?
|
| Middle Aged | 17 | 2025 | 7111 | 0.510 |
Why?
|
| Female | 19 | 2025 | 15074 | 0.480 |
Why?
|
| Male | 17 | 2025 | 13424 | 0.430 |
Why?
|
| Osteoarthritis, Knee | 2 | 2024 | 25 | 0.400 |
Why?
|
| Double-Blind Method | 7 | 2022 | 414 | 0.380 |
Why?
|
| Cognitive Dysfunction | 2 | 2024 | 263 | 0.360 |
Why?
|
| Aged, 80 and over | 7 | 2025 | 2015 | 0.330 |
Why?
|
| Phantom Limb | 2 | 2020 | 9 | 0.330 |
Why?
|
| Foot | 2 | 2020 | 23 | 0.310 |
Why?
|
| Risk Factors | 3 | 2023 | 2078 | 0.280 |
Why?
|
| Stroke Rehabilitation | 3 | 2022 | 11 | 0.270 |
Why?
|
| Spinal Cord Injuries | 2 | 2018 | 56 | 0.270 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 957 | 0.250 |
Why?
|
| Neurovascular Coupling | 2 | 2024 | 154 | 0.250 |
Why?
|
| Treatment Outcome | 6 | 2022 | 2367 | 0.240 |
Why?
|
| Self-Help Devices | 1 | 2025 | 4 | 0.240 |
Why?
|
| Cognition | 2 | 2025 | 322 | 0.240 |
Why?
|
| Niacinamide | 1 | 2025 | 31 | 0.230 |
Why?
|
| Hyperalgesia | 1 | 2024 | 16 | 0.230 |
Why?
|
| NAD | 1 | 2025 | 100 | 0.230 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2024 | 38 | 0.220 |
Why?
|
| Reproducibility of Results | 3 | 2024 | 769 | 0.220 |
Why?
|
| Motor Cortex | 2 | 2021 | 48 | 0.220 |
Why?
|
| Pain, Postoperative | 1 | 2024 | 62 | 0.220 |
Why?
|
| Pain Measurement | 1 | 2024 | 166 | 0.210 |
Why?
|
| Pain Threshold | 1 | 2024 | 89 | 0.210 |
Why?
|
| Cerebral Small Vessel Diseases | 1 | 2023 | 14 | 0.210 |
Why?
|
| Life Style | 1 | 2023 | 89 | 0.200 |
Why?
|
| Dietary Supplements | 1 | 2025 | 240 | 0.200 |
Why?
|
| Peripheral Arterial Disease | 1 | 2025 | 137 | 0.200 |
Why?
|
| White Matter | 1 | 2023 | 89 | 0.190 |
Why?
|
| Parents | 1 | 2023 | 128 | 0.190 |
Why?
|
| Biomechanical Phenomena | 2 | 2019 | 179 | 0.190 |
Why?
|
| Lipids | 1 | 2023 | 207 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 817 | 0.180 |
Why?
|
| Glucose | 1 | 2023 | 204 | 0.180 |
Why?
|
| Hypertension | 1 | 2023 | 308 | 0.170 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 120 | 0.170 |
Why?
|
| Neural Pathways | 1 | 2020 | 120 | 0.160 |
Why?
|
| Mobility Limitation | 1 | 2019 | 15 | 0.160 |
Why?
|
| Recurrence | 1 | 2020 | 321 | 0.160 |
Why?
|
| Comorbidity | 1 | 2020 | 257 | 0.160 |
Why?
|
| Brain Ischemia | 1 | 2020 | 85 | 0.160 |
Why?
|
| Muscle Spasticity | 1 | 2018 | 3 | 0.160 |
Why?
|
| Muscle Stretching Exercises | 1 | 2018 | 20 | 0.160 |
Why?
|
| Equipment and Supplies | 1 | 2018 | 12 | 0.150 |
Why?
|
| Forefoot, Human | 1 | 2017 | 3 | 0.140 |
Why?
|
| Perceptual Disorders | 1 | 2017 | 4 | 0.140 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2017 | 14 | 0.140 |
Why?
|
| Time Factors | 1 | 2020 | 1590 | 0.130 |
Why?
|
| Autonomic Nervous System | 1 | 2017 | 112 | 0.130 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 967 | 0.120 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 633 | 0.100 |
Why?
|
| Endothelium, Vascular | 2 | 2025 | 325 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2025 | 430 | 0.090 |
Why?
|
| Amputees | 2 | 2020 | 7 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2021 | 2541 | 0.080 |
Why?
|
| Recovery of Function | 2 | 2018 | 116 | 0.070 |
Why?
|
| Pyridinium Compounds | 1 | 2025 | 27 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2025 | 188 | 0.060 |
Why?
|
| Accidental Falls | 1 | 2024 | 32 | 0.060 |
Why?
|
| Fasting | 1 | 2024 | 81 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2025 | 156 | 0.060 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2024 | 74 | 0.060 |
Why?
|
| Equipment Design | 1 | 2025 | 217 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2024 | 193 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 1 | 2024 | 220 | 0.050 |
Why?
|
| Paresis | 1 | 2022 | 5 | 0.050 |
Why?
|
| Muscle Strength | 1 | 2024 | 230 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 91 | 0.050 |
Why?
|
| Mitochondria | 1 | 2025 | 369 | 0.050 |
Why?
|
| Prognosis | 1 | 2024 | 802 | 0.050 |
Why?
|
| Telemedicine | 1 | 2024 | 174 | 0.050 |
Why?
|
| Diagnostic Errors | 1 | 2021 | 32 | 0.050 |
Why?
|
| Young Adult | 2 | 2020 | 2714 | 0.040 |
Why?
|
| Hand | 1 | 2021 | 26 | 0.040 |
Why?
|
| Chile | 1 | 2020 | 9 | 0.040 |
Why?
|
| Latin America | 1 | 2020 | 9 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2025 | 667 | 0.040 |
Why?
|
| Thrombectomy | 1 | 2020 | 28 | 0.040 |
Why?
|
| Basal Ganglia | 1 | 2020 | 10 | 0.040 |
Why?
|
| Amputation | 1 | 2020 | 42 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 118 | 0.040 |
Why?
|
| Lower Extremity | 1 | 2020 | 84 | 0.040 |
Why?
|
| Video Recording | 1 | 2019 | 39 | 0.040 |
Why?
|
| Arm | 1 | 2018 | 37 | 0.040 |
Why?
|
| Pain | 1 | 2021 | 258 | 0.040 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2018 | 22 | 0.040 |
Why?
|
| Pressure | 1 | 2018 | 90 | 0.040 |
Why?
|
| Rotation | 1 | 2017 | 9 | 0.040 |
Why?
|
| Ankle Joint | 1 | 2017 | 16 | 0.040 |
Why?
|
| Hip Joint | 1 | 2017 | 19 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 2018 | 89 | 0.030 |
Why?
|
| Aging | 1 | 2024 | 968 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 104 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 134 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 2017 | 170 | 0.030 |
Why?
|
| Adult | 2 | 2020 | 7703 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2017 | 391 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 719 | 0.030 |
Why?
|
| Heart Rate | 1 | 2017 | 379 | 0.030 |
Why?
|